Massachusetts General Hospital (MGH; Boston, MA) has received a National Institutes of Health (NIH; Bethesda, MD) grant totaling $1,449,151 for its Center for Biomedical OCT Research and Translation (CBORT). CBORT, whose principal investigator is Strategies in Biophotonics advisory board member Brett Bouma and began in 2011, aims to bring groundbreaking advances in optical coherence tomography (OCT) to biomedicine.
Related: OCT symposium emphasizes key applications
CBORT, which comprises faculty and researchers from MGH and Harvard Medical School (Cambridge, MA), looks to address the deficient accessibility of cutting-edge OCT instrumentation and technology through the innovation of new technical capabilities that are motivated by significant biological and clinical challenges, and through translation, facilitated by direct collaboration. In CBORT's launch, its members have initiated six driving biomedical projects and, through extensive discussions, have jointly identified specific technical projects that will have significant biological and clinical impact. The selected projects naturally fall into three core thematic areas: advanced structural imaging, functional and compositional contrast, and hybrid imaging modalities.
For more information, please visit http://octresearch.org.